arrow
P

Paolo Strati

The University of Texas MD Anderson Cancer Center
H指数:42
被引数:6,431

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term clinical outcomes from the smart start trial: rituximab, lenalidomide and ibrutinib in patients with newly diagnosed large B-cell lymphoma

SMART START试验的长期临床结果:利妥昔单抗、来那度胺和伊布替尼在 newly diagnosed large B-cell lymphoma 患者中的应用

2026-07-020
OAAI
Real-World Outcomes and Toxicities of CAR-T in Relapsed/Refractory Follicular Lymphoma: A Multicenter Cohort Study

真实世界CAR-T治疗复发/难治性滤泡性淋巴瘤的疗效和毒性:一项多中心队列研究

2026-03-020
OAAI
Axicabtagene ciloleucel in combination with rituximab for refractory large B cell lymphoma: the phase 2, single-arm ZUMA-14 trial

Axicabtagene ciloleucel联合利妥昔单抗治疗难治性大b细胞淋巴瘤: 2期单臂ZUMA-14试验

2026-01-050
OAAI
Frontline acalabrutinib, lenalidomide and rituximab for advanced stage follicular lymphoma with high tumor burden: phase II trial

一线阿卡巴鲁替尼、来那度胺和利妥昔单抗治疗高肿瘤负荷的晚期滤泡性淋巴瘤:II期试验

2025-08-070
OAAI
A phase 2 study of obinutuzumab combined with lenalidomide in previously untreated high tumor burden follicular lymphoma

一项奥滨尤妥珠单抗联合来那度胺治疗既往未治的高肿瘤负荷滤泡性淋巴瘤的II期研究

2025-06-170
OAAI
Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T Therapy

COVID-19中的细胞因子风暴、噬血细胞性淋巴组织细胞增生症,以及CAR-T疗法

2025-04-071
OA
Characterization of Lymphopenia and Correlating the Risk of Cytopenias With Dose and Bone Marrow Volume Irradiated in Aggressive B Cell Lymphoma Patients Bridged With Radiation Therapy for Chimeric Antigen Receptor-T Cell Therapy
2025-03-010
PRE
Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas
2025-01-310
OAAI
Evaluation of Outcomes and Toxicities of Commercial Axicabtagene Ciloleucel (axi-cel) and Tisagenlecleucel (tisa-cel) for Relapsed or Refractory (R/R) Follicular Lymphoma (FL): Real-World Evidence (RWE) from 10 US Academic Centers

评估商业用Axicabtagene Ciloleucel(axi-cel)和Tisagenlecleucel(tisa-cel)治疗复发或难治性(R/R)滤泡性淋巴瘤(FL)的结局和毒性的研究:来自10家美国学术中心的真实世界证据(RWE)

BLOOD
IF23.1
2024-11-050
PRE
Radiation Therapy and Monocyte Activation in Large B-Cell Lymphoma Patients Treated with CAR T-Cell Therapy

放射治疗与接受CAR T细胞疗法的大B细胞淋巴瘤患者的单核细胞激活

BLOOD
IF23.1
2024-11-050
PRE
Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial
2024-07-014
PRE
A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma

预防性anakinra减轻大b细胞淋巴瘤患者ICANS的1期研究

2023-11-1416
OAAI
Prolonged cytopenia following CD19 CAR T cell therapy is linked with bone marrow infiltration of clonally expanded IFNg-expressing CD8 T cells

CD19 CAR T细胞治疗后的长期血细胞减少与克隆扩增的表达IFNg的CD8 T细胞的骨髓浸润有关

2023-08-0121
OAAI